● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
● In relation to the value of its tangible assets, the company's valuation appears relatively high.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
● Over the past four months, analysts' average price target has been revised downwards significantly.